title: BioIntraface®: the next quantum in medical devices.
abstract: BioIntraface®, Inc., located in Riverside, Rhode Island, was formed in February of 2009 to commercialize its biomaterials surface treatment technologies. The platform technologies involve the creation of economical, multifunctional metal oxide and polymer materials and coatings to control the bioactivity and antimicrobial properties of medical devices and implants. Biointraface® has continued optimizing and validating coatings for promising applications in orthopaedics, dentistry, catheters, wound dressings, topical antimicrobial products, and cosmetics applications. It has also obtained third-party verification of ISO biocompatibility testing for eight coatings with increasing levels of antimicrobial agents, where no cytotoxicity was indicated and similar tests showing long lasting antimicrobial efficacy against multiple strains of bacteria.
authors: John D
authors: JD
authors: Jarrell
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001709:Biotechnology / Q000639:trends*; D020099:Coated Materials, Biocompatible / Q000737:chemistry / Q000494:pharmacology; D055808:Drug Discovery; D006801:Humans; D008422:Materials Testing / Q000379:methods*; D019736:Prostheses and Implants; D012237:Rhode Island
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D020099:Coated Materials, Biocompatible
keywords: antimicrobial coatings; medical devices; metal oxide and polymer coatings